文献速递慢性静脉疾病

踝下入路非热非肿胀技术治疗静脉性溃疡与C5期病变

Inframalleolar access in endovenous treatment of venous ulcers and C5 disease with nonthermal nontumescent techniques.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2021-08-02

单中心回顾性研究纳入109例晚期静脉疾病患者,采用踝下入路行ClariVein或ScleroSafe非热非肿胀消融,术后1周疼痛中位数由5降至1(P=.0001),30天和90天创面完全愈合率分别为43.7%和71%,无神经或皮肤损伤报告。

要点

  • 踝下入路NTNT消融可有效促进静脉性溃疡愈合
  • 术后疼痛显著改善且无神经损伤风险
  • 静脉功能不全复发率低,溃疡复发1例

核心结论

  • 踝下入路非热非肿胀消融技术治疗晚期静脉疾病有效且安全,无神经损伤风险。

研究设计与样本

  • 单中心回顾性研究,纳入2018年5月至2020年3月期间接受踝下入路治疗的109例晚期静脉疾病患者。

主要发现

  • 术后1周疼痛评分(范围0-10)中位数从术前5(IQR 3-6)降至1(IQR 0-2),P=.0001。
  • 30天创面完全愈合38例(43.7%),90天完全愈合71例(81.6%)。
  • 溃疡复发1例,静脉功能不全复发6例,无神经或皮肤损伤报告。

临床怎么用

  • 对于晚期静脉疾病伴溃疡或C5期病变,可考虑采用踝下入路的NTNT消融技术。
  • 该技术有助于促进溃疡愈合、减轻疼痛,且不增加神经损伤风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the use of inframalleolar access for endovenous ablation when treating advanced venous disease with nonthermal nontumescent (NTNT) techniques. METHODS: This single-center retrospective study included 109 patients with advanced venous disease, treated using inframalleolar access between May 2018 and March 2020. NTNT techniques included ClariVein (Merit Medical Systems, South Jordan, Utah) and ScleroSafe (VVT Medical, Kefar Sava, Israel). Outcomes measured were postprocedure pain, leg edema, ulcer healing and recurrence rates, and venous insufficiency recurrence. RESULTS: Seventy-seven patients (70%) were treated with ClariVein and 32 (30%) with ScleroSafe. Postprocedure pain score (range, 0-10) after 1 week decreased from a preprocedure median of 5 (interquartile range, 3-6) to 1 ((interqartiel range, 0-2) (P = .0001). Complete wound healing was achieved in 38 patients (43.7%) after 30 days and in 71 patients (81.6%) after 90 days. One patient developed an ulcer recurrence and six developed venous insufficiency recurrence. There was no reported nerve or skin injuries. CONCLUSIONS: NTNT ablation techniques using inframalleolar access are effective and safe without risk of nerve damage. Their use facilitates ulcer healing and limits pain in patients with advanced disease.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Avrahami M, Silverberg D, Elias S, et al. Inframalleolar access in endovenous treatment of venous ulcers and C5 disease with nonthermal nontumescent techniques. J Vasc Surg Venous Lymphat Disord. 2021. PMID: 34352423. doi:10.1016/j.jvsv.2021.07.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。